Compare MDU Resources Group Inc. Common Stock (Holding Company) (MDU) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MDU Resources Group Inc. Common Stock (Holding Company) vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? MDU Resources Group Inc. Common Stock (Holding Company) trades at $18.56 (market cap $3.92B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.87 (market cap $2.51B). The key difference: MDU Resources Group Inc. Common Stock (Holding Company) is the larger of the two by market cap, and MDU Resources Group Inc. Common Stock (Holding Company) pays a 3.03% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold MDU Resources Group Inc. Common Stock (Holding Company) for 0 Days and SELLAS Life Sciences Group Inc. Common Stock for 0 Days on average.
| MDU | SLS | |
|---|---|---|
Market Cap | $3.92B | $2.51B |
Volume | 1,027,656 | 6,359,048 |
Sector | Utilities | Health |
52-Week High | $22.80 | $15.46 |
52-Week Low | $18.39 | $1.39 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $6.45B | $2.37B |
Dividend Yield | 3.03% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SELLAS Life Sciences (SLS) trades at $12.41, up 4.02% today, with a bullish technical signal from moving averages but mixed oscillators. The company reported no revenue in 2025, with a net loss of $26.86 million, negative ROE and ROA, and a high P/B ratio of 18.2. Recent news includes a law firm investigation into investor claims and positive preclinical data for SLS009 in pancreatic cancer models presented at the AACR conference.
The outlook hinges on upcoming clinical trial results, particularly the Phase 3 REGAL trial for GPS in AML, with topline data expected in Q4 2026. While analyst consensus is unanimously bullish, significant risks include the binary nature of trial outcomes, ongoing legal scrutiny, and persistent negative profitability metrics. The stock's recent surge of ~300% year-to-date reflects high investor optimism but also heightened volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About MDU Resources Group Inc. Common Stock (Holding Company)
MDU Resources Group, Inc. is a US holding company operating regulated electric and natural gas utility services alongside a construction materials and services business supplying asphalt, concrete, and aggregates.
Read more on MDU →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
